Joel S - Search Results

1

Enhancing the in vitro cytotoxic activity of Delta9-tetrahydrocannabinol in leukemic cells through a combinatorial approach.

Liu WM, Scott KA, Shamash J, Joel S, Powles TB. Liu WM, et al. Among authors: joel s. Leuk Lymphoma. 2008 Sep;49(9):1800-9. doi: 10.1080/10428190802239188. Leuk Lymphoma. 2008. PMID: 18608861

2

The schedule-dependent effects of etoposide in leukaemic cell lines: a function of concentration and duration.

Liu WM, Joel SP. Liu WM, et al. Cancer Chemother Pharmacol. 2003 Apr;51(4):291-6. doi: 10.1007/s00280-003-0579-y. Epub 2003 Mar 5. Cancer Chemother Pharmacol. 2003. PMID: 12721756

3

In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma.

Shamash J, Salam AH, Davies DC, Williams A, Joel S, Lister TA. Shamash J, et al. Among authors: joel s. Br J Cancer. 1998 May;77(10):1598-603. doi: 10.1038/bjc.1998.262. Br J Cancer. 1998. PMID: 9635834 Free PMC article.

4

The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR-ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents.

Liu WM, Stimson LA, Joel SP. Liu WM, et al. Among authors: joel sp. Br J Cancer. 2002 May 6;86(9):1472-8. doi: 10.1038/sj.bjc.6600288. Br J Cancer. 2002. PMID: 11986783 Free PMC article.

5

Exposure to low concentrations of etoposide reduces the apoptotic capability of leukaemic cell lines.

Liu WM, Oakley PR, Joel SP. Liu WM, et al. Among authors: joel sp. Leukemia. 2002 Sep;16(9):1705-12. doi: 10.1038/sj.leu.2402621. Leukemia. 2002. PMID: 12200685

6

Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity.

Liu WM, Powles T, Shamash J, Propper D, Oliver T, Joel S. Liu WM, et al. Among authors: joel s. Oncogene. 2004 Jan 29;23(4):981-90. doi: 10.1038/sj.onc.1207294. Oncogene. 2004. PMID: 14647427

7

Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway.

Powles T, te Poele R, Shamash J, Chaplin T, Propper D, Joel S, Oliver T, Liu WM. Powles T, et al. Among authors: joel s. Blood. 2005 Feb 1;105(3):1214-21. doi: 10.1182/blood-2004-03-1182. Epub 2004 Sep 28. Blood. 2005. PMID: 15454482 Free article.

8

A comparison of the platinum analogues in bladder cancer cell lines.

Powles T, Perry J, Shamash J, Liu W, Oliver T, Joel S. Powles T, et al. Among authors: joel s. Urol Int. 2007;79(1):67-72. doi: 10.1159/000102917. Urol Int. 2007. PMID: 17627172

9

The importance of drug scheduling and recovery phases in determining drug activity. Improving etoposide efficacy in BCR-ABL-positive CML cells.

Liu WM, Lawrence AJ, Joel SP. Liu WM, et al. Among authors: joel sp. Eur J Cancer. 2002 Apr;38(6):842-50. doi: 10.1016/s0959-8049(02)00016-3. Eur J Cancer. 2002. PMID: 11937320

10

GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.

Shamash J, Powles T, Ansell W, Berney D, Stebbing J, Mutsvangwa K, Wilson P, Asterling S, Liu S, Wyatt P, Joel SP, Oliver RT. Shamash J, et al. Among authors: joel sp. Br J Cancer. 2007 Aug 6;97(3):308-14. doi: 10.1038/sj.bjc.6603865. Epub 2007 Jul 3. Br J Cancer. 2007. PMID: 17609665 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters